Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in
  • Log out

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
  • Log out
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
The Clinical Picture

Secondary syphilis

Emma Coleman, DO, Andre Fiahlo, MD and Andrei Brateanu, MD, FACP
Cleveland Clinic Journal of Medicine July 2017, 84 (7) 510-511; DOI: https://doi.org/10.3949/ccjm.84a.16089
Emma Coleman
Internal Medicine Residency Program, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: colemae4@ccf.org
Andre Fiahlo
GI/Hepatology Fellowship, University of Florida, Jacksonville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Brateanu
Department of Internal Medicine, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 39-year old man presented to the emergency department reporting several weeks of generalized weakness, headache, nausea, and migratory arthralgia. The patient had exclusively had sex with men, had participated in condomless anal insertive and receptive intercourse, and had been in a monogamous relationship during the past 6 months.

See related editorial, page 514

Physical examination revealed a painful ulcerated plaque on the upper lip (Figure 1), a macular rash with 3 crater-like scarred painless lesions (considered to be healing chancres) on the glans (Figure 2), a nonpruritic hyperkeratotic maculopapular palmar rash, and bilateral submandibular lymphadenopathy. No alopecia, gummas, neurologic deficits, or ocular or cardiovascular abnormalities were noted.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Ulcerated plaque on the upper lip.

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Macular rash with painless scarred lesions.

Results of laboratory testing included a positive reactive syphilis immunoglobulin G (IgG) enzyme immunoassay and a positive rapid plasma reagin (RPR) test (titer 1:256). Human immunodeficiency virus (HIV) testing was negative, and serologic testing demonstrated prior immunization to hepatitis B virus. Given the clinical presentation and laboratory findings, secondary syphilis was considered the most probable diagnosis.

The patient was treated with benzathine penicillin G 2.4 million units intramuscularly.

SYPHILIS: A REEMERGING CONDITION

Epidemiology

The rate of reported primary and secondary syphilis cases in the United States has risen since 2001.1 Most cases occur in men who have sex with men.1 Additional risk factors include condomless intercourse and drug use.2

Signs and symptoms of the 3 stages

Primary syphilis begins 2 to 3 weeks after inoculation of a mucosal surface.3 This stage is marked by one or more painless chancres and, in some cases, local nontender lymphadenopathy.3,4 Secondary syphilis presents 4 to 8 weeks later with systemic symptoms including rash, classically involving the palms or soles’ lymphadenopathy, myalgia, fever, and weight loss.2,3 Untreated primary and secondary syphilis may progress to latent or asymptomatic disease.5

Tertiary syphilis, defined by the US Centers for Disease Control and Prevention (CDC) as gummas or cardiovascular syphilis, occurs 15 to 30 years after an untreated exposure.4,6 Neurosyphilis can present at any stage of the disease.6

Diagnosis

The diagnosis of syphilis involves a nontreponemal test such as RPR or Venereal Disease Research Laboratory (VDRL) to screen for disease, followed by a treponemal antibody test such as fluorescent treponemal antibody-absorption, Treponema pallidum particle agglutination assay, or syphilis IgG to confirm the diagnosis.5 There is no screening test for tertiary disease in patients previously diagnosed with primary or secondary syphilis, but a cerebrospinal fluid (CSF) examination is recommended if neurologic or ocular manifestations are present.6

Treatment

Treatment of primary, secondary, and early latent syphilis is a single dose of 2.4 million units of benzathine penicillin G given intramuscularly.7 The treatment of late latent and tertiary syphilis is less well defined by the current literature but generally includes penicillin.7

Patients with primary and secondary syphilis undergo serologic and clinical evaluation at 6 and 12 months to be assessed for treatment failure or reinfection.6 Patients with latent disease require serologic follow-up at 6, 12, and 24 months.6 Additionally, CSF analysis should be done if baseline high titers do not fall within 12 to 24 months of treatment or if symptoms suggest syphilis.6 Patients with neurosyphilis often require CSF evaluation every 6 months.6 Follow-up for patients with tertiary syphilis is less well defined.

Patients coinfected with HIV have special needs and considerations, as outlined in the CDC’s 2015 Sexually Transmitted Diseases Treatment Guidelines.6

Sexual contacts of patients with syphilis deserve evaluation. Exposure within 90 days of a patient’s diagnosis with primary, secondary, or latent disease requires treatment regardless of the results of serologic testing.6 Persons exposed more than 90 days before diagnosis may undergo serologic testing; however, if results are not immediately available or follow-up is unlikely, the individual should be treated for early syphilis.6 If serologic testing results are negative, no treatment is required.6

  • Copyright © 2017 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Centers for Disease Control and Prevention (CDC)
    . 2015 Sexually transmitted disease surveillance. www.cdc.gov/std/stats15/. Accessed May 22, 2017.
  2. ↵
    1. Nyatsanza F,
    2. Tipple C
    . Syphilis: presentations in general medicine. Clin Med (Lond) 2016; 16:184–188.
    OpenUrl
  3. ↵
    1. French P
    . Syphilis. BMJ 2007; 334:143–147. Erratum in: BMJ 2007; 335:0.
    OpenUrlFREE Full Text
  4. ↵
    1. Centers for Disease Control and Prevention (CDC)
    . Appendix C1. Case definitions for nationally notifiable infectious diseases. www.cdc.gov/std/stats14/appendixc.htm. Accessed May 18, 2017.
  5. ↵
    1. Centers for Disease Control and Prevention (CDC)
    . Syphilis—CDC fact sheet (detailed). www.cdc.gov/std/syphilis/STDFact-Syphilis-detailed.htm. Accessed May 18, 2017.
  6. ↵
    1. Centers for Disease Control and Prevention (CDC)
    . 2015 Sexually transmitted diseases treatment guidelines. Syphilis. www.cdc.gov/std/tg2015/syphilis.htm. Accessed June 15, 2016.
  7. ↵
    1. Clement ME,
    2. Okeke NL,
    3. Hicks CB
    . Treatment of syphilis: a systematic review. JAMA 2014; 312:1905–1917.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (7)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 7
1 Jul 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Secondary syphilis
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Secondary syphilis
Emma Coleman, Andre Fiahlo, Andrei Brateanu
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 510-511; DOI: 10.3949/ccjm.84a.16089

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Secondary syphilis
Emma Coleman, Andre Fiahlo, Andrei Brateanu
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 510-511; DOI: 10.3949/ccjm.84a.16089
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • SYPHILIS: A REEMERGING CONDITION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Syphilis 100 years later: Another lost opportunity?
  • PubMed
  • Google Scholar

Cited By...

  • Syphilis 100 years later: Another lost opportunity?
  • Google Scholar

More in this TOC Section

  • Mass under the lip
  • Oral leukoplakia and oral cancer
  • Median rhomboid glossitis caused by tongue-brushing
Show more The Clinical Picture

Similar Articles

Subjects

  • Men's Health
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire